Oxford Science Enterprises
Oxford, UK-based investment company and venture builder that commercializes University of Oxford research, holding preferred-investor status on the university's spinouts.
Oxford Science Enterprises (OSE) is an Oxford, UK-based investment company and venture builder that commercializes research from the University of Oxford, acting as the university's preferred investor for spinouts -- Oxford receives a share of OSE's equity stake in each spinout it backs. OSE runs as an evergreen, patient-capital vehicle rather than a fixed-term fund, investing from pre-seed through growth stage across deep tech, life sciences, and health tech; it reports a GBP1.3bn net asset value and has backed 50+ companies with 300+ co-investors. OSE co-led the 2024 seed round and 2026 seed extension for AI-inference-chip startup Fractile.
Overview
- Firm
- Oxford Science Enterprises
- Headquarters
- Oxford, UK
- Founded
- 2015
- AUM
- GBP1.3bn net asset value (per company site)
- Stages
- Pre-seed, Seed, Series A, Growth
- Thesis
- Evergreen, patient-capital vehicle investing pre-seed through growth stage in deep tech, life sciences, and health tech, primarily via University of Oxford spinouts; receives a share of the university's equity stake in each spinout it backs.
Portfolio companies1
Partners0
No linked records yet.
Frequently asked
- What is Oxford Science Enterprises?
- Evergreen, patient-capital vehicle investing pre-seed through growth stage in deep tech, life sciences, and health tech, primarily via University of Oxford spinouts; receives a share of the university's equity stake in each spinout it backs.
- How much does Oxford Science Enterprises manage?
- Oxford Science Enterprises manages GBP1.3bn net asset value (per company site) in assets, and was founded in 2015.
- What stages does Oxford Science Enterprises invest at?
- Oxford Science Enterprises invests at Pre-seed, Seed, Series A, Growth.
Sources & citations2
Each claim links to its underlying source. Confidence reflects how directly the source supports the claim.
- 1
Oxford Science Enterprises is an independent investment company and venture builder, powered by its partnership with the University of Oxford, investing across deep tech, life sciences, and health tech with a GBP1.3bn net asset value
Oxford Science Enterprises: Oxford Science Enterprises -- Shareholder Portal / What We DoVerified2026-08-05 - 2
Fractile secured a further $22.5M from Nato Innovation Fund, Kindred, and Oxford Science Enterprises in January 2026, separate from its 2024 $15M seed and 2026 $220M Series B
Sifted: AI chip startup Fractile secures $22.5m from Nato Innovation Fund, Kindred, Oxford Science EnterprisesReported2026-01-15